The Illinois Medical Cannabis Advisory Board will consider whether 15 new medical conditions should be eligible for treatment under the state's medical marijuana pilot program.
The board is expected to hold a public hearing on the issue Monday. Among the new conditions under review are irritable bowel syndrome, post-traumatic stress disorder, Lyme disease, osteoarthritis, chronic paid, diabetes, migraines, autism and chronic low-level depression.
The Rauner administration has already shot down two previous recommendations from the advisory board to expand the health conditions eligible for medical marijuana treatment. The administration has argued that the medical marijuana program is in its early stages and should not be expanded before it can be evaluated.
Illinois' pilot program for medical marijuana already covers patients with specific debilitating medical conditions, such as cancer, multiple sclerosis, and HIV/AIDS.